Literature DB >> 10424356

Mechanisms of hypoxic pulmonary vasoconstriction: can anyone be right?

J P Ward1, P I Aaronson.   

Abstract

Despite extensive studies over many years. there is still no real consensus regarding the mechanisms responsible for hypoxic pulmonary vasoconstriction (HPV). This is partially related to extensive variation between preparations, species, and the length of the hypoxic challenge, but also to an apparent abundance of potential mechanisms. Whereas there is good evidence that hypoxia causes inhibition of K channels in pulmonary artery smooth muscle, with subsequent depolarisation and Ca2+ influx through voltage-activated Ca2+ channels, there is also strong support for a critical role for Ca2+ release from intracellular stores. Moreover other studies suggest that the endothelium provides an essential component of the overall response. We suggest in this review that sustained HPV, as seen in the intact animal, is multi-factorial in origin and requires activation of more than one process for the full response to develop. Fundamental issues that remain unresolved are outlined.

Entities:  

Mesh:

Year:  1999        PMID: 10424356     DOI: 10.1016/s0034-5687(99)00025-0

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  21 in total

1.  Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.

Authors:  Fiona Murray; Margaret R MacLean; Nigel J Pyne
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Regulation of nitric oxide consumption by hypoxic red blood cells.

Authors:  Tae H Han; Erion Qamirani; Allyson G Nelson; Daniel R Hyduke; Gautam Chaudhuri; Lih Kuo; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

3.  Mobilization of sarcoplasmic reticulum stores by hypoxia leads to consequent activation of capacitative Ca2+ entry in isolated canine pulmonary arterial smooth muscle cells.

Authors:  Lih Chyuan Ng; Sean M Wilson; Joseph R Hume
Journal:  J Physiol       Date:  2004-12-21       Impact factor: 5.182

4.  Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure.

Authors:  Eun Bok Baek; Hae Young Yoo; Su Jung Park; Hyang Sun Kim; Seong Deok Kim; Yung E Earm; Sung Joan Kim
Journal:  Pflugers Arch       Date:  2008-06-10       Impact factor: 3.657

5.  Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism.

Authors:  Kenneth R Olson; Nathan L Whitfield; Shawn E Bearden; Judy St Leger; Erika Nilson; Yan Gao; Jane A Madden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

6.  Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism.

Authors:  Tony Fracasso; Heidi Pfeiffer; Cristina Sauerland; Andreas Schmeling
Journal:  Int J Legal Med       Date:  2010-07-10       Impact factor: 2.686

7.  Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries.

Authors:  Sergey V Smirnov; Richard Beck; Paolo Tammaro; Tetsuro Ishii; Philip I Aaronson
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

8.  Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat.

Authors:  T P Robertson; D Hague; P I Aaronson; J P Ward
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

Review 9.  Hypoxic pulmonary vasoconstriction: mechanisms and controversies.

Authors:  Philip I Aaronson; Tom P Robertson; Gregory A Knock; Silke Becker; Tristan H Lewis; Vladimir Snetkov; Jeremy P T Ward
Journal:  J Physiol       Date:  2005-10-27       Impact factor: 5.182

Review 10.  ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes.

Authors:  Yong-Xiao Wang; Yun-Min Zheng
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.